BDFS Capital LLC Buys Shares of 7,393 Colgate-Palmolive Company $CL

BDFS Capital LLC purchased a new stake in shares of Colgate-Palmolive Company (NYSE:CL) during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 7,393 shares of the company’s stock, valued at approximately $584,000.

Other large investors also recently modified their holdings of the company. Teacher Retirement System of Texas grew its stake in shares of Colgate-Palmolive by 35.3% during the fourth quarter. Teacher Retirement System of Texas now owns 469,624 shares of the company’s stock valued at $37,110,000 after buying an additional 122,634 shares during the last quarter. Citigroup Inc. grew its position in Colgate-Palmolive by 43.7% during the 3rd quarter. Citigroup Inc. now owns 1,346,590 shares of the company’s stock worth $107,646,000 after acquiring an additional 409,710 shares during the last quarter. GAMMA Investing LLC grew its holdings in Colgate-Palmolive by 114.2% in the 4th quarter. GAMMA Investing LLC now owns 23,329 shares of the company’s stock worth $1,843,000 after acquiring an additional 12,437 shares during the last quarter. Grantham Mayo Van Otterloo & Co. LLC increased its position in shares of Colgate-Palmolive by 217.0% in the third quarter. Grantham Mayo Van Otterloo & Co. LLC now owns 40,605 shares of the company’s stock valued at $3,246,000 after acquiring an additional 27,796 shares during the period. Finally, Avior Wealth Management LLC bought a new position in shares of Colgate-Palmolive during the fourth quarter valued at about $1,135,000. 80.41% of the stock is currently owned by institutional investors.

Colgate-Palmolive Trading Down 0.9%

Shares of CL opened at $89.74 on Friday. Colgate-Palmolive Company has a 1-year low of $74.54 and a 1-year high of $99.33. The company has a current ratio of 1.02, a quick ratio of 0.67 and a debt-to-equity ratio of 16.33. The firm’s 50-day moving average price is $87.32 and its 200-day moving average price is $86.58. The firm has a market capitalization of $71.81 billion, a price-to-earnings ratio of 34.92, a PEG ratio of 4.78 and a beta of 0.33.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings results on Friday, May 1st. The company reported $0.97 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.94 by $0.03. Colgate-Palmolive had a net margin of 10.04% and a return on equity of 386.76%. The company had revenue of $5.32 billion during the quarter, compared to the consensus estimate of $5.22 billion. During the same period in the prior year, the firm earned $0.91 earnings per share. Colgate-Palmolive’s revenue was up 8.4% on a year-over-year basis. Sell-side analysts anticipate that Colgate-Palmolive Company will post 3.81 EPS for the current year.

Colgate-Palmolive Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, August 14th. Stockholders of record on Monday, July 20th will be given a $0.53 dividend. The ex-dividend date of this dividend is Monday, July 20th. This represents a $2.12 annualized dividend and a dividend yield of 2.4%. Colgate-Palmolive’s dividend payout ratio is currently 82.49%.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on CL. UBS Group increased their target price on shares of Colgate-Palmolive from $98.00 to $100.00 and gave the stock a “buy” rating in a report on Monday, May 4th. Wall Street Zen downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Sunday, March 29th. Morgan Stanley reiterated an “overweight” rating on shares of Colgate-Palmolive in a report on Monday, May 4th. Royal Bank Of Canada reiterated an “outperform” rating and issued a $102.00 price objective on shares of Colgate-Palmolive in a research report on Monday, May 4th. Finally, Bank of America reduced their target price on Colgate-Palmolive from $105.00 to $102.00 and set a “buy” rating on the stock in a research note on Friday, April 10th. Twelve analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $95.88.

About Colgate-Palmolive

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.